Skip to Main Navigation Skip to Main Content Skip to Footer
search play2 play3 facebook twitter linkedin2 cross instagram
ASCP
  • DASHBOARD
  • STORE
  • LOGOUT
  • STORE
  • LOGIN
Menu
  • Jobs
  • ASCP
  • User Auth Test Page
  • Many Americans Reportedly Lack Access To Test-To-Treat Program

    Kaiser Health News (4/15, Recht) reported the Biden Administration’s “‘test-to-treat’ program, announced in March, is meant to reduce [COVID-19] hospitalizations and deaths by quickly getting antiviral pills to people who test positive,” yet, “even as cas...
    Full Article
  • Increased Concentrations Of Glucocorticoid In Hair May Be Marker For Decreased CD4 Cell Counts Among Patients With HIV Infection, Study Indicates

    Infectious Disease Advisor (4/15, Nye) reported, “Increased concentrations of glucocorticoid in hair may be a marker for decreased CD4 cell counts among patients with HIV infection, according to results of a study” in which researchers sought “to evaluate...
    Full Article
  • White House Urges People Over 60 To Get Second COVID-19 Booster

    The New York Times (4/17, Lamb) reports people “over 60 should get a second booster shot of a coronavirus vaccine, Dr. Ashish K. Jha, the new White House COVID-19 response coordinator, said on Sunday, citing ‘pretty compelling’ new data from Israel indica...
    Full Article
  • Experts Warn Of Another Potential COVID-19 Surge Driven By BA.2

    The AP (4/15, Ungar) reported the US is again “trudging into what could be another COVID-19 surge, with cases rising nationally and in most states after a two-month decline.” Experts “warn that the coming wave – caused by” the BA.2 Omicron subvariant “tho...
    Full Article
  • Scientists Thinking Of New Ways To Discuss COVID-19 Risks

    The New York Times (4/17, A1, Mueller) reports that now, even as COVID-19 “case numbers begin to climb again and more infections go unreported, the onus has fallen on individual Americans to decide how much risk they and their neighbors face from the coro...
    Full Article
  • WHO’s Public Release Of Global COVID-19 Death Toll Reportedly Delayed By Objections From India

    The New York Times (4/16, A1, Nolen, Singh) reported, “An ambitious effort by the World Health Organization to calculate the global death toll from the coronavirus pandemic has found that vastly more people died than previously believed – a total of about...
    Full Article
  • Global COVID-19 Deaths Higher On Weekends Than Weekdays, Study Finds

    Bloomberg (4/16, Fox) reported global COVID-19 fatalities “on weekends have been higher compared to weekdays during the pandemic, according to” findings “due to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases...
    Full Article
  • COVID-19 Vaccine Booster Increases Immune Defenses In School-Aged Children, Particularly Against Omicron Variant, Pfizer & BioNTech Say

    The Washington Post (4/14, Johnson) reports, “A booster shot of the Pfizer-BioNTech vaccine increases immune defenses against the coronavirus in school-aged children, particularly against the omicron variant, the companies announced Thursday.” The compani...
    Full Article
  • US Increasingly Turning To Wastewater Surveillance To Monitor COVID-19 Spread

    The Washington Post (4/14, Sun, Keating) reports that “as the United States enters year three of the coronavirus pandemic, disease trackers are trying to stay one step ahead of the constantly evolving virus – by hunting for it in” wastewater. Wastewater s...
    Full Article
  • Both Saliva, Gargle Samples Effective For Detection Of SARS-CoV-2 Infection Via Reverse Transcription Polymerase Chain Reaction Assay, Meta-Analysis Finds

    Infectious Disease Advisor (4/14, van Paridon) reports, “Both saliva and gargle samples were effective for the detection of SARS-CoV-2 infection via reverse transcription polymerase chain reaction...assay, and the detection rate with saliva was increased...
    Full Article
  • Case Counts Becoming An Increasingly Unreliable Measure Of Coronavirus’ Toll, Scientists Say

    The New York Times (4/14, Anthes) reports that “as Americans increasingly turn to at-home tests, states shutter mass testing sites and institutions cut back on surveillance testing, case counts are becoming an increasingly unreliable measure of the virus’...
    Full Article
  • Carriage Of Extended-Spectrum B-Lactamase-Producing Enterobacterales Found To Be More Common Among MSM On HIV PrEP, MSM With HIV Infection In Study

    Infectious Disease Advisor (4/14, Nye) reports, “Carriage of extended-spectrum b-lactamase-producing enterobacterales...was found to be more common among men who have sex with men (MSM) on HIV pre-exposure prophylaxis (PrEP) and MSM with HIV infection,” a...
    Full Article
  • Omicron Subvariant BA.2 Dominating US COVID-19 Cases Without Triggering New Surge

    The Wall Street Journal (4/14, Kamp, Abbott, Subscription Publication) reports the Omicron subvariant BA.2 has made up the majority of new COVID-19 cases in the US for the past few weeks without triggering a new surge. Specifically, the variant is affecti...
    Full Article
  • Study Shows Continued Ability Of Real-Time Genomic Surveillance To Detect Nosocomial Outbreaks

    Healio (4/14, Gallagher, Stulpin) reports findings from a follow-up study “continued to show the ability of real-time genomic surveillance to detect nosocomial outbreaks.” In the previous study, researchers “demonstrated that a combination of whole-genome...
    Full Article
  • FDA Grants Emergency Use Authorization To COVID-19 Breathalyzer Test

    Bloomberg (4/14, Muller) reports, “A Covid-19 breathalyzer test with the ability to provide diagnostic results in three minutes has won emergency-use authorization from the U.S. Food and Drug Administration, the agency announced Thursday.” The test made b...
    Full Article
  • FDA Extends Review Of Application For Full Approval Of Regeneron’s COVID-19 Antibody Therapy

    Reuters (4/14, Khandekar, Roy) reports, “The U.S. Food and Drug Administration has extended by three months its review of Regeneron Pharmaceuticals Inc’s application for the full approval of its COVID-19 antibody therapy [casirivimab and imdevimab], the U...
    Full Article
  • CDC Extends Air, Public Transit Mask Mandate For Two More Weeks

    The New York Times (4/13, Murphy) reports, “Despite great pressure from airlines, the hospitality industry and Republican lawmakers to lift the rule requiring masks on planes and other public transportation, the Centers for Disease Control and Prevention...
    Full Article
  • US Renews COVID-19 Public Health Emergency For Three More Months

    Reuters (4/13, Aboulenein) reports, “The United States on Wednesday renewed the COVID-19 public health emergency, allowing millions of Americans to keep getting free tests, vaccines and treatments for at least three more months.” The emergency “was due to...
    Full Article
  • Digital Droplet Polymerase Chain Reaction More Accurate Than Reverse Transcription-Quantitative Polymerase Chain Reaction For Diagnosing SARS-CoV-2 Infection Among Hospitalized Patients, Study Finds

    Infectious Disease Advisor (4/13, Nye) reports that “among hospitalized patients, digital droplet polymerase chain reaction...was more accurate than reverse transcription-quantitative polymerase chain reaction...for the diagnosis of” SARS-CoV-2 infection,...
    Full Article
  • Specific Gut Microbiota Found To Be Markers For More Favorable Immune Responses To And Decreased Rate Of Adverse Effects From COVID-19 Vaccination

    Gastroenterology Advisor (4/13, Nye) reports, “Specific gut microbiota were found to be markers for more favorable immune responses to and decreased rate of adverse effects from COVID-19 vaccination, according to study findings.” The research was publishe...
    Full Article
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • »
Footer
Chicago (Headquarters)
33 West Monroe Street, Suite 1600, Chicago, IL 60603

Privacy Policy 

Terms of Use

Follow Us

Copyright ©2021  by American Society for Clinical Pathology. All Rights Reserved.

Chat With BOC

close
First Name *
Last Name *
Email *
Customer ID

Request a Call from Customer Relations

Close
Name *
Topic *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id